ANI FDA Wednesday, August 30, 2017 0.00 Neutral

FDA Approves Unknown Drug — ANI PHARMS

ANI PHARMS announced August 30, 2017, approval of ANDA 203447 for a generic substance, potentially challenging the current market supply as the company prepares to introduce the therapeutic.

View original filing at SEC.gov →

AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day